Hospira Issues a Voluntary Nationwide Recall For One Lot Of 0.25% Bupivacaine Hydrochloride Injection, USP Due to The Presence Of Particulate Matter Within a Single Vial - FDA Safety Alerts & Drug Recalls

Lake Forest, IL - Hospira, Inc., a Pfizer company, is voluntarily recalling one lot of 0.25% Bupivacaine Hydrochloride Injection, USP (NDC: 0409-1159-02, Lot 59-064- DK, Expiry 1NOV2017) at the hospital/retail level due to the presence of particulate matter within a single vial. The issue was identified through a confirmed complaint.

from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/2aYBLA6
via IFTTT